2m 2m 2m 2m 2m 2m 2m
INHIBIKASE THRP (IKT)
NASDAQ
$1.68+$0.005 (+0.30%)
Price as of Jun 03, 2026 4:55 PM EDT- $231.1MMarket Cap
- -15.66%1-Year Change
- BiotechnologyIndustry
INHIBIKASE THRP (IKT)
$1.68+$0.005 (+0.30%)
Earnings Score
Valuation | IKT | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | 0 | ||
Growth | 0 | ||
Low Earnings Volatility | 3 |
Momentum Score
Valuation | IKT | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | 0.52% | ||
12-Month Momentum | -4.43% | ||
3-Month Risk Adjusted Momentum | 2.04% | ||
12-Month Risk Adjusted Momentum | -6.24% |
True Yield
Valuation | IKT | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | N/A | ||
Net Debt Paydown Yield | 0.03% |
Financial Health Score
Valuation | IKT | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | -11 |